All past events
-
4 March 2019,
09:00-13:00
Join us at an exciting CeBIL/CORS seminar on 4 March 2019 featuring gene-editing pioneer Feng Zhang from the Broad Institute, as well as legal and regulatory experts.
» Read more
-
20 November 2018,
12:00-13:00
Risk communication in the 21st century: challenges and opportunities ahead.
» Read more
-
2 November 2018,
10:00-13:00
An outline of the legal developments leading up to the most recent decisions related to investment protection in the pharmaceutical industry and the legal challenges arising from these issues.
» Read more
-
15 October 2018,
09:00-11:30
Traditional innovation models emphasize the prominent role of the producer as the source of innovation, and this logic still often dominates research, practice and policy approaches to innovation.
» Read more
-
8 October 2018,
15:00-18:30
Artificial intelligence, advanced machine learning and Big Data will transform the health & life sciences. While offering amazing possibilities, there is no doubt that these technologies raise many legal questions with regard to IP, liability, patient involvement, bias, discrimination, competition etc. They will also disrupt traditional value chains and structures in the health care sector.
» Read more
-
7 September 2018,
08:45-17:30
This one-day symposium, co-hosted by CeBIL and the Centre for Law, Medicine and Life Sciences (LML) at the University of Cambridge, aims to tackle some of the challenging issues raised by black-box precision medicine, particularly for legal and regulatory frameworks. Black-box precision medicine is an exciting new frontier in health care diagnostics, harnessing the power of big data and artificial intelligence to examine newly available troves of health data, including genomic sequences, patient clinical care records, and the results of diagnostic tests.
» Read more
-
4 September 2018,
15:00-18:00
The protection of trade secrets is becoming ever more important. With the EU-Directive a common European legal framework has been established. This seminar uses the Directive as a prism for looking into international practices (Japan), national implementation (Denmark) and specific issues and technologies (public private partnerships and medical diagnosis).
» Read more
-
22 August 2018,
09:00-11:00
A CeBIL mini-seminar with Novartis Head of Legal Digital Matt Owens & Head of IP Strategy Isabelle Schubert.
» Read more
-
21 June 2018,
16:00-18:00
Two prominent international experts and CeBIL partners speak on crucial legal issues in medical AI and precision medicine.
» Read more
-
25 May 2018,
11:00-14:00
A starting point of both regional and international research collaboration.
» Read more
